Related Experiment Video
Updated: May 29, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is
Florie Borel1, Ruiqi Han, Allerdien Visser
1Department of Research & Development, Amsterdam Molecular Therapeutics, Amsterdam, The Netherlands.
Unlabelled:
Adenosine triphosphate (ATP)-binding cassette (ABC) transporters are drug efflux pumps responsible for the multidrug resistance phenotype causing hepatocellular carcinoma (HCC) treatment failure. Here we studied the expression of 15 ABC transporters relevant for multidrug resistance in 19 paired HCC patient samples (16 untreated, 3 treated by chemotherapeutics). Twelve ABC transporters showed up-regulation in HCC compared with adjacent healthy liver. These include ABCA2, ABCB1, ABCB6, ABCC1, ABCC2, ABCC3, ABCC4, ABCC5, ABCC10, ABCC11, ABCC12, and ABCE1. The expression profile and function of some of these transporters have not been associated with HCC thus far. Because cellular microRNAs (miRNAs) are involved in posttranscriptional gene silencing, we hypothesized that regulation of ABC expression in HCC might be mediated by miRNAs. To study this, miRNAs were profiled and dysregulation of 90 miRNAs was shown in HCC compared with healthy liver, including up-regulation of 11 and down-regulation of 79. miRNA target sites in ABC genes were bioinformatically predicted and experimentally verified in vitro using luciferase reporter assays. In total, 13 cellular miRNAs were confirmed that target ABCA1, ABCC1, ABCC5, ABCC10, and ABCE1 genes and mediate changes in gene expression. Correlation analysis between ABC and miRNA expression in individual patients revealed an inverse relationship, providing an indication for miRNA regulation of ABC genes in HCC.
Conclusion:
Up-regulation of ABC transporters in HCC occurs prior to chemotherapeutic treatment and is associated with miRNA down-regulation. Up-regulation of five ABC genes appears to be mediated by 13 cellular miRNAs in HCC patient samples. miRNA-based gene therapy may be a novel and promising way to affect the ABC profile and overcome clinical multidrug resistance.
Insights
Adenosine triphosphate (ATP)-binding cassette (ABC) transporters are upregulated in hepatocellular carcinoma (HCC) before treatment. MicroRNAs (miRNAs) may regulate these transporters, offering potential for new HCC therapies to overcome drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) treatment failure is often caused by multidrug resistance mediated by Adenosine triphosphate (ATP)-binding cassette (ABC) transporters.
- Understanding the regulation of ABC transporters in HCC is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the expression of ABC transporters in HCC patient samples.
- To explore the role of microRNAs (miRNAs) in regulating ABC transporter expression in HCC.
Main Methods:
- Analysis of 15 ABC transporters in 19 paired HCC and adjacent healthy liver samples.
- miRNA profiling in HCC versus healthy liver tissues.
- Bioinformatic prediction and in vitro luciferase reporter assays to validate miRNA-ABC gene interactions.
Main Results:
- Twelve ABC transporters were found to be upregulated in HCC tissues compared to healthy liver.
- Dysregulation of 90 miRNAs was observed in HCC, with 11 upregulated and 79 downregulated.
- Thirteen miRNAs were confirmed to target and mediate expression changes in five specific ABC genes (ABCA1, ABCC1, ABCC5, ABCC10, ABCE1).
Conclusions:
- ABC transporter upregulation in HCC occurs early, even before chemotherapy, and is linked to miRNA downregulation.
- A subset of miRNAs directly regulates key ABC genes in HCC.
- miRNA-based therapeutic strategies hold promise for overcoming multidrug resistance in HCC.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cell Specific Gene Expression
MicroRNAs
MicroRNAs
Master Transcription Regulators

